Lauren Brown, Editor
Published July 29, 2025
In today’s competitive healthcare market, clinics are presented with an expanding array of regenerative technologies. While devices like radial pressure wave systems and focused acoustic wave systems are often mentioned in the same conversation, their mechanisms of action, clinical impact, and business value differ greatly. These differences carry real consequences for patient outcomes, workflow efficiency, and practice growth.
This analysis compares Zimmer’s pneumatic shockwave technology with StemWave’s electrohydraulic acoustic wave system to help providers make informed decisions.
Radial pressure vs. focused acoustic energy
Zimmer’s enPuls system uses pneumatic radial pressure wave technology, generating a high-pressure, air-driven projectile inside the handpiece. When the projectile strikes a transmitter, mechanical pulses disperse outward in a cone-shaped pattern. Energy reaches only superficial tissue layers, typically no deeper than 5 mm, with intensity dropping by more than 80% beyond that depth.
StemWave, in comparison, utilizes electrohydraulic acoustic wave technology—one of the most advanced forms of therapy available. This system penetrates up to 12 cm (nearly five inches) into tissue. The energy is delivered precisely to stimulate blood flow and regeneration to the inflamed or damaged tissue (without the microtrauma). This makes it especially effective for addressing chronic degeneration and inflammation in areas that superficial treatments can’t reach.
Clinical efficacy comparison: Patient outcomes and treatment protocols
Zimmer’s radial pressure wave technology has demonstrated benefits in superficial muscle tightness and mild tendon irritation. Treatments rely on preset parameters and general application, which can miss deep trigger points. Sessions typically last 15-20 minutes, and treatment plans often require 10-15 visits to achieve modest improvement.
StemWave, with its focused acoustic energy, delivers higher therapeutic impact in shorter sessions of just 5-10 minutes. Treatment plans typically involve 8-10 visits, and practices consistently report measurable improvement after the first session. Focused delivery ensures targeted therapy, leading to 80-95% positive outcomes and higher patient satisfaction.
Patients experience reduced pain, improved mobility, and faster return to activity. Providers see increased patient buy-in and retention and more referrals thanks to predictable, excellent results.
Clinical evidence analysis: research and long-term outcomes
Peer-reviewed studies have documented the limitations of radial pressure waves in treating deep or calcified conditions because they can’t deliver sufficient energy beyond superficial layers. Research supports the greater depth and precision of focused acoustic waves in treating conditions like plantar fasciitis with calcification, patellar tendinopathy, and deep bursitis.
Long-term outcome data for focused acoustic wave therapy show higher rates of sustained symptom resolution and improved function compared to radial methods. StemWave’s electrohydraulic technology aligns with these findings, making it a superior choice for treating chronic and complex musculoskeletal conditions.
Limitations assessment
An honest evaluation of each system highlights the specific limitations providers should weigh before making a decision.
Zimmer enPuls limitations: Radial energy doesn’t penetrate deeply enough for many chronic conditions, making it more appropriate for mild, superficial issues. Longer treatment times and more sessions can frustrate patients and providers.
StemWave limitations: Not suitable for patients with active cancer at the treatment site, pacemakers, or bleeding disorders. Most patients, however, tolerate the therapy well with minimal side effects.
Provider decision framework considerations
When selecting regenerative technology, providers should weigh the following:
- Depth of treatment. For deeper or more chronic conditions, focused acoustic therapy provides greater therapeutic value.
- Clinical applications. Radial systems may suffice for soft tissue tightness, but focused systems excel with tendinopathies, calcifications, and post-surgical rehab.
- Patient experience. StemWave’s ability to use real-time feedback during treatment ensures more precise and personalized care.
- Training and support. StemWave’s intuitive system requires minimal training, with ongoing support provided to ensure seamless integration.
Practice impact analysis: Implementation, workflow, and ROI
Integrating both devices remains simple, but StemWave’s Platinum Provider Program is the first of its kind to be released. The program comes with a dedicated Client Success Manager along with a full clinical advisory team ready to assist you in the ways you and your clinic need.
Workflow integration is also more efficient with StemWave. Focused sessions are shorter and more targeted, designed to free up your staff and schedule to do more, for less.
Financially, clinics offering StemWave treatments typically generate $5,000-25,000 in additional monthly revenue. The cash-based model, with session prices at about $100-$200, delivers a clear return on investment within months.
The bottom line: Depth, control, and predictable results
Zimmer helped introduce radial pressure wave therapy to the mainstream, offering a non-invasive option for mild, surface-level conditions.
But as regenerative care advances, more clinicians are choosing focused acoustic wave therapy for its precision, depth, and reliability. StemWave delivers measurable outcomes in deeper tissue, greater treatment control, and the operational efficiency that superficial methods can’t offer.
For clinics aiming to elevate their standard of care, shorten recovery timelines, and scale with a premium cash-based model, StemWave is more than just a device—it’s a clinical and strategic advantage.
Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are those of medical professionals and are based on a collective analysis of publicly available studies and data. Our company’s product is a Class I medical device, and while it may be related to the topics discussed in this post, it is important to note that our product may not cause similar effects as stated in the post. Additionally, this post should not be interpreted as a guarantee of any specific outcome or result. It’s important to consult with a qualified healthcare professional for personalized medical advice and treatment. We encourage readers to consult the FDA’s website for information on our product’s clearance and any relevant labeling information.
Author: Tom Kostopoulos, CEO
Published 7/24/2025
Like this blog? Learn more about the Revolutionary technology reshaping traditional healthcare here.
For decades, healthcare providers have navigated the complexities of insurance reimbursements, endless paperwork, and shrinking margins. But in recent years, something remarkable has begun to shift. Patients are no longer defaulting to the traditional insurance-driven system. They’re looking for faster, more transparent, and more effective solutions. They want something that works, and they’re willing to pay out of pocket for it.
This shift marks a turning point in healthcare delivery, one that challenges the status quo. And for forward-thinking providers it creates a powerful opportunity to offer more personalized, results-driven care on your own terms.
Why patients are looking beyond insurance covered services
Today’s patients are more informed and more empowered than ever and frankly many patients are frustrated by the high deductibles and copayment costs they receive without feeling improvement to justify the spend. In fact, a recent study by John Hopkins, actually showed instances where uninsured cash-based prices were actually more affordable for patients than insured rates. The added bonus? Self-pay options empower patients by giving them additional care options that may not be otherwise accessible due to lack of insurance or pre-approval hoops.
The truth is people have grown frustrated with long wait times, limited treatment options, and impersonal care dictated by insurance companies. In many cases, patients with chronic pain or mobility issues have already “tried it all.” They’ve gone through prescriptions, injections, and referrals, only to be left with side effects or little progress.
So what are they doing instead?
They’re seeking direct-pay providers who offer solutions that offer…
- noticeable improvement
- lasting pain relief
- increased mobility
- a way to address the root cause and avoid recurrence
This shift has opened the door for regenerative, non-invasive treatments like StemWave’s Cellular Response Therapy (CRT). It’s a treatment that speaks to the heart of what these patients want: rapid results without surgery or medications.
The provider’s perspective: Freedom and growth
From the clinic’s standpoint, cash-based services offer a level of freedom and stability that’s become increasingly difficult to find in the insurance world. No more waiting 90 days for a partial reimbursement. No more restrictive treatment protocols. No more volume-based burnout.
With cash-pay treatments like StemWave, clinics are seeing:
- $5,000-$25,000 increase in monthly revenue
- Shorter, more efficient appointments, typically lasting just 5-10 minutes
- More flexibility within their business model, where providers choose their own pricing and can align with the value and results delivered
- Higher patient satisfaction and referral rates
In short, providers are finally able to take back control. They can offer care on their terms using technology that actually moves the needle for their patients.
What makes StemWave ideal for a cash-pay model?
Cash-pay success hinges on delivering undeniable value. That’s exactly where StemWave shines. With CRT, patients often experience noticeable improvement after just one session. Over the course of 8 to 10 treatments, practices regularly report 80 to 95 percent improvement across a wide range of musculoskeletal conditions.
This level of performance is what makes patients say, “It was worth every penny.” And in a cash-pay model, that’s exactly the response you want.
Positioning your practice for the future
The cash-pay movement isn’t going away. In fact, it’s expanding across multiple healthcare sectors, especially among providers who want to stand out in a crowded market. As insurance becomes more limiting and patients become more selective, the clinics that offer premium, effective treatments will be the ones that thrive.
StemWave helps you future-proof your practice by offering:
- A non-invasive, in-demand solution that patients trust
- A cash-based service model that increases revenue and autonomy
- Marketing and training support to help you hit the ground running
Your next step toward growth
If you’ve ever felt stuck chasing reimbursements, undervaluing your care, or overworking your staff to make ends meet, there is a better way.
The rise of cash-pay healthcare is not just a trend. It is a movement. And with StemWave, your clinic can be at the forefront of it.
Disclosure Statement: The content provided in this blog post is for informational purposes only and should not be considered medical advice. The opinions expressed are those of medical professionals and are based on a collective analysis of publicly available studies and data. Our company’s product is a Class I medical device, and while it may be related to the topics discussed in this post, it is important to note that our product may not cause similar effects as stated in the post. Additionally, this post should not be interpreted as a guarantee of any specific outcome or result. It’s important to consult with a qualified healthcare professional for personalized medical advice and treatment. We encourage readers to consult the FDA’s website for information on our product’s clearance and any relevant labeling information.
